Global analyses of Chromosome 17 and 18 genes of lung telocytes compared with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes by unknown
Wang et al. Biology Direct  (2015) 10:9 
DOI 10.1186/s13062-015-0042-0RESEARCH Open AccessGlobal analyses of Chromosome 17 and 18 genes
of lung telocytes compared with mesenchymal
stem cells, fibroblasts, alveolar type II cells, airway
epithelial cells, and lymphocytes
Jian Wang†, Ling Ye†, Meiling Jin and Xiangdong Wang*Abstract
Background: Telocytes (TCs) is an interstitial cell with extremely long and thin telopodes (Tps) with thin segments
(podomers) and dilations (podoms) to interact with neighboring cells. TCs have been found in different organs,
while there is still a lack of TCs-specific biomarkers to distinguish TCs from the other cells.
Results: We compared gene expression profiles of murine pulmonary TCs on days 5 (TC5) and days 10 (TC10) with
mesenchymal stem cells (MSCs), fibroblasts (Fbs), alveolar type II cells (ATII), airway basal cells (ABCs), proximal
airway cells (PACs), CD8+ T cells from bronchial lymph nodes (T-BL), and CD8+ T cells from lungs (T-LL). The
chromosome 17 and 18 genes were extracted for further analysis. The TCs-specific genes and functional networks
were identified and analyzed by bioinformatics tools. 16 and 10 of TCs-specific genes were up-regulated and 68
and 22 were down-regulated in chromosome 17 and 18, as compared with other cells respectively. Of them,
Mapk14 and Trem2 were up-regulated to indicate the biological function of TCs in immune regulation, and
up-regulated MCFD2 and down-regulated E4F1 and PDCD2 had an association with tissue homeostasis for
TCs. Over-expressed Dpysl3 may promote TCs self-proliferation and cell-cell network forming.
Conclusions: The differential gene expression in chromosomes 17 and 18 clearly revealed that TCs were the
distinctive type of interstitial cells. Our data also indicates that TCs may play a dual role in immune
surveillance and immune homoeostasis to keep from immune disorder in acute and chronic pulmonary
diseases. TCs also participated in proliferation, differentiation and regeneration.
Reviewers: This article was reviewed by Qing Kay Li and Dragos Cretoiu.
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Telocytes (TCs) have been proposed as a new type of
interstitial cells with extremely long telopodes (Tps),
which were recognized in different organs, such as trachea
and lung [1,2], oesophagus [3], intestine [4], liver [5], kid-
ney [6], heart [7,8], skin [9], eyes [10], urinary tract [11],* Correspondence: Xiangdong.wang@clintransmed.org
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unless otherwise stated.bladder [12], uterus [13], prostate gland [14], and euro-
muscular spindles [15], as documented on www.telocytes.
com. TCs were found to form a three-dimensional net-
work in close contacts with blood vessels, nerve bundles
and cells of the local immune system [8,13,16-18]. There
is growing evidence to support that TCs have close asso-
ciations with stem cells and will be a critical player in re-
generation medicine [10,19]. TCs may also take part in
immune regulation, proliferation, cellular reparation and
fibrosis. However, there are no specific biomarkers to
distinguish TCs from other tissue-resident cells. The
reliable way to identify TCs is dependent on the specificThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Summary of genes expressed preferentially in
TCs, as compared with others in chromosome 17
Compaired pairs/fold up-regulated >1 >2 >5
TC5 vs. others 47 4 2
TC10 vs. others 22 4 2
TCs vs. others 15 0 1
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tremely long Tps with podomers and podoms by trans-
mission electron microscopy (TEM) [20]. TCs present
positive CD34, c-kit and vimentin by immunohistochem-
istry [19] and other markers like iNOS, caveolin-1, VEGF-D
and PDGFRα were also identified to indicate various immu-
nophetypes of TCs existed in different organs [4,21].
Our previous study initially approved the existence of
TCs in the trachea and lung tissues of the mouse and
human [1,22,23]. We compared genes expression profiles
of murine TCs with mesenchymal stem cells (MSCs) and
fibroblasts (Fbs) and proteomic profiles of human lung
TCs and Fbs to explore TC-specific markers and their bio-
logical function [24,25]. MicroRNA signature was also
used to differentiate TCs from other interstitial cells [26].
Furthermore, we revealed features and patterns of genes
in chromosomes 1 by comparing gene expression profiles
of murine pulmonary TCs, MSCs, Fbs, alveolar type II
cells (ATII), airway basal cells (ABCs), proximal airway
cells (PACs), CD8+ T cells from bronchial lymph nodes
(T-BL), and CD8+ T cells from lungs (T-LL) by global ana-
lyses [27]. The similar work has been done to detect pat-
terns of TCs-specific genes in chromosome 2 and 3, and
showed that TCs played an important role in tissue injury
and aging, inhibition of tissue inflammation, tumor pro-
motion, and development of pulmonary fibrosis and other
interstitial lung diseases [28]. However, features and pat-
terns of TCs-specific genes in other chromosomes have
not been uncovered, and potential function of TCs still
remained unclear.
The present study aimed at investigating features and
patterns of TCs-specific gene profiles and exploring po-
tential function of TCs by focusing in chromosomes 17
and 18. The significant difference in gene expression
profiles of murine pulmonary TCs on days 5 (TC5) and
days 10 (TC10) with the other cells, MSCs, Fbs, ATII,
ABCs, PACs, T-BL and T-LL were compared to identify
TCs-specific genes and the functional networks were
identified by bioinformatics tools.
Methods
Cell sampling and data collection
Gene expression profiles of murine pulmonary TCs on
days 5 and 10, MSCs and Fbs were obtained from our pre-
vious study [24]. TCs were isolated from BALB/c mouse
lung tissue and cultured for 5 and 10 days, respectively.
MSCs and Fbs were obtained from Sciencell Research
Laboratories (M7500-57, Carlsbad, CA, USA) and Chinese
Academy of Science (GNM28, Shanghai, China), re-
spectively. ATII, ABCs, PACs, T-BL, T-LL gene expres-
sion profiles were obtained from the National Center
for Biotechnology Information (NCBI) Gene Expression
Omnibus database (GSE6846, GSE27379, GSE28651) [29].
Alveolar type II cells (GSM157835-GSM157837) wereisolated from 8 weeks old sex age matched littermate con-
trol mice. CD8+ T-cells from lungs and bronchial lymph
nodes (GSM677065) and CD8+ T-cells from bronchial
lymph nodes, lymphocytes (GSM677065) derived from
mice (CL4). Murine proximal airway duct (GSM709834-
GSM709836) and basal cells (GSM709832, GSM709833)
were isolated from 8–12 week old C57BL/6 mice.
Data mining and preprocessing
The gene expression profiles of murine lung TCs, MSCs
and Fbs from our previous study contained 23861
probes. About 13236 probes and 11532 genes were de-
fined after eliminating the probes without corresponding
official symbols. Gene expression of ATII, ABCs, PACs,
T-BL, and T-LL from GEO originally included 45,101
probes. 5684 probes without corresponding official symbols
were eliminated and 39,417 probes and 21,680 genes were
obtained. Data integration and genes detected in all the
samples were selected to analysis, of which 11532 genes
were elected finally. Totally, 582 genes of the chromosome
17 and 267 genes of the chromosome 18 were focused and
furthermore analyzed in the present study.
Identification of differentially expressed genes
Gene expression data were normalized and imported into
Agilent GeneSpring GX software (version 11.5.1) for fur-
ther analysis. Differentially expressed genes between two
samples were identified through Fold Change filtering as
our previous research [27]. The propensity of functional
changes was reflected in different levels of the gene
expression in each cell types. The genes in TCs on days 5
and 10, which were up- or down-regulated more than one-
fold compared with other cells, were identified as TCs-
specific genes in the present study. Up- or down-regulated
folds of TCs genes were calculated by comparing with
other cells, after the averages of gene expression in cells
were obtained from the raw data of multi-databases, as
shown in Additional files 1 and 2.
Results
Fifty three genes were up-regulated and 92 down-regulated
in chromosome 17 of TC5 as compared with other cells,
and 28 genes were up-regulated and 167 down-regulated
in TC10. Of genes up or down-regulated at TC5 and
TC10, 16 over-expressed genes (i.e. 2900073G15Ri, Ccnd3,
Chtf18, Clic1, Fem1a, Fez2, Kifc1, Mapk14, Mcfd2, Mtch1,
Table 2 Summary of genes expressed preferentially in
TCs, as compared with others in chromosome 17
Compaired pairs/fold down-regulated >1 >2 >5
TC5 vs. others 83 9 0
TC10 vs. others 146 21 0
TCs vs. others 67 1 0
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in chromosome 17 of TCs. Among them, Trem2 was up-
regulated over five folds in TC5 and TC10, as compared
with others. Sixty eight genes were down-regulated in
TC5 and TC10, of which C030034I22Rik was expressed
in TCs 2–5 folds lower than in other cells (Tables 1, 2, 3
and 4). In chromosome 18, we found 22 up-regulated
genes and 31 down-regulated genes in TC5 and 15 up-
regulated genes and 57 down-regulated genes in TC10 as
compared with other cells. Eleven genes (9430020K01Rik,
Bin1, Cdh2, Fech, Txnl4a, Usp14, Yipf5, Dpysl3, Lims2,
Tubb6) were up-regulated and 22 genes down-regulated
(fold >1). Among them, Dpysl3, Lims2 and Tubb6 were
up-regulated 2–5 folds in TC5 and TC10, while Scgb3a2
and Zfp397 was expressed in TCs 2–5 folds lower than
other cells (Tables 5, 6, 7 and 8).
In chromosome 17 the number of up- and down-
regulated genes more than one-fold in TC5 was 332 and
250, 330 and 252, 184 and 398, 232 and 350, 223 and
359,153 and 429, or 192 and 390, as compared with MSCs,Table 3 The up-regulated fold of specific genes in TCs as com
Folds(TC5 vs. others/TC10 vs. others)
(A) Genes up-regulated between one- and twofold in TCs as compared
Gene symbol Fibroblast Stem ATII
2900073G15Rik 2.90/1.87 1.81/1.17 2.81/1.81
Ccnd3 2.49/2.33 2.37/2.22 1.40/1.31
Chtf18 2.41/1.86 1.45/1.12 4.34/3.35
Clic1 3.64/2.26 2.10/1.30 2.01/1.25
Fem1a 1.99/1.67 1.86/1.56 2.24/1.87
Fez2 3.14/2.86 1.87/1.71 9.51/8.69
Kifc1 2.23/2.42 1.10/1.19 8.53/9.27
Mapk14 1.57/1.02 1.71/1.11 7.98/5.19
Mcfd2 1.04/1.03 1.38/1.37 1.24/1.23
Mtch1 2.24/1.63 1.66/1.20 2.73/1.98
Pgp 1.25/1.20 1.72/1.65 1.50/1.44
Tbcc 2.63/2.04 1.97/1.53 2.34/1.82
Tubb4 4.41/3.16 1.77/1.27 4.23/3.04
Tubb5 3.95/2.55 1.76/1.13 5.87/3.79
Zfand3 1.53/1.26 1.47/1.21 4.12/3.39
(B) Genes up-regulated between five- and tenfold in TCs as compared
Trem2 15.11/76.80 36.31/184.56 30.83/156.68Fbs, ATII, ABCs, PACs, T-BL or T-LL, respectively. The
number of up- and down-regulated genes more than one-
fold in TC10 was 226 and 356, 245 and 337, 139 and 443,
194 and 388,177 and 405, 120 and 462, or 146 and 436, as
compared with MSCs, Fbs, ATII, ABCs, PACs, T-BL or
T-LL, respectively. The number of up- and down-regulated
genes in TC5 and TC10 was 220 and 244, 229 and 236,
134 and 393, 185 and 341,170 and 352, 112 and 421, or
142 and 386, as compared with MSCs, Fbs, ATII, ABCs,
PACs, T-BL or T-LL, respectively (Table 9). In chromo-
some 18 the number of up- and down-regulated genes in
TC5 was 190 and 77, 173 and 94, 73 and 194, 92 and 175,
85 and 182, 54 and 213, or 58 and 209, as compared with
MSCs, Fbs, ATII, ABCs, PACs, T-BL or T-LL, respectively.
The number of up- and down-regulated genes in TC10
was 152 and 115, 140 and 127, 58 and 209, 69 and 198, 74
and 193, 44 and 223, or 49 and 218, as compared with
MSCs, Fbs, ATII, ABCs, PACs, T-BL or T-LL, respectively.
The number of up- and down-regulated genes in TC5 and
TC10 was 143 and 68, 130 and 84, 52 and 188, 66 and
172, 69 and 177, 41 and 210, or 48 and 208, as compared
with MSCs, Fbs, ATII, ABCs, PACs, T-BL or T-LL, re-
spectively (Table 10). The detailed genes were shown in
Additional files 3 and 4.
Hierarchical clustering of genes in chromosomes 17 and
18 was performed by TIGR Multi-experiment Viewer
(MeV v4.9), respectively (Figure 1A and B). The physical
and functional interaction of specific genes was furtherpared with others in chromosome 17
with others
CD8_T_BL CD8_T_LL Basal_cell Duct_cell
4.89/3.16 3.79/2.45 3.70/2.45 3.45/2.22
1.47/1.38 1.73/1.62 2.44/1.62 5.29/4.96
2.24/1.72 12.43/9.59 5.69/9.59 2.39/1.84
2.37/1.47 3.10/1.93 2.45/1.93 1.94/1.21
6.71/5.62 7.09/5.94 1.22/5.94 1.31/1.10
3.84/3.51 4.21/3.85 3.11/3.85 3.49/3.19
1.91/2.08 1.05/1.14 5.49/1.14 4.52/4.91
3.38/2.20 3.96/2.57 1.96/2.57 2.63/1.71
2.88/2.85 3.35/3.31 6.02/3.31 4.26/4.22
88.12/64.07 144.31/104.92 35.78/104.92 27.26/19.82
2.85/2.73 2.99/2.86 3.01/2.86 4.71/4.51
2.85/2.21 2.84/2.20 1.81/2.20 1.87/1.45
13.43/9.63 40.35/28.94 8.72/28.94 2.66/1.90
2.81/1.82 4.11/2.66 4.28/2.66 3.33/2.15
3.50/2.89 5.50/4.53 4.37/4.53 5.48/4.51
with others
25.98/132.03 51.13/259.88 30.45/259.88 44.38/225.54
Table 4 The down-regulated fold of specific genes in TCs as compared with others in chromosome 17
Folds(TC5 vs others/TC10 vs others)
(A) Genes up-regulated between one- and twofold in TCs as compared with others
Gene symbol Fibroblast Stem ATII CD8_T_BL CD8_T_LL Basal_cell Duct_cell
1600014C23Rik 2.69/3.97 1.21/1.78 12.47/18.43 2.66/3.93 2.55/3.77 9.29/13.72 7.04/10.40
2310061I04Rik 1.54/1.80 1.27/1.49 6.68/7.82 3.66/4.29 3.06/3.58 6.36/7.44 6.74/7.89
4930539E08Rik 1.40/1.69 1.07/1.29 5.65/6.83 31.25/37.81 38.16/46.16 32.79/39.68 24.54/29.69
5430411C19Rik 2.30/2.15 1.13/1.05 3.40/3.18 23.14/21.65 15.46/14.47 7.61/7.12 14.76/13.81
A630033E08Rik 2.67/3.15 1.24/1.46 7.91/9.35 29.81/35.22 41.89/49.49 20.02/23.65 6.67/7.88
Atl2 1.32/1.84 2.22/3.10 21.29/29.73 14.23/19.88 13.07/18.25 33.45/46.71 32.74/45.72
Atp6v1g2 1.05/1.44 1.72/2.36 2.20/3.02 1.80/2.47 1.61/2.20 2.38/3.26 3.17/4.34
BC003965 2.62/2.97 1.70/1.93 8.77/9.92 21.82/24.69 17.18/19.44 39.62/44.82 25.30/28.62
BC011426 1.06/1.32 1.25/1.56 5.65/7.04 15.51/19.30 18.28/22.76 1.50/1.86 3.09/3.85
BC051142 1.12/1.60 1.16/1.67 1.38/1.98 2.89/4.15 1.45/2.08 3.18/4.58 2.00/2.87
Cdc5l 1.79/1.69 2.19/2.08 171.49/162.64 269.71/255.80 210.90/200.03 271.87/257.85 238.68/226.37
Clpp 1.05/1.06 1.63/1.64 6.30/6.34 4.95/4.97 3.45/3.47 8.03/8.08 7.75/7.79
Cox7a2l 1.42/2.18 1.21/1.87 1.41/2.17 3.45/5.30 2.34/3.60 4.80/7.39 3.91/6.02
Dpp9 1.33/1.63 1.44/1.76 18.97/23.22 8.31/10.17 5.90/7.22 3.96/4.84 2.59/3.17
Dpy30 1.38/2.23 1.11/1.78 6.93/11.15 12.89/20.76 7.90/12.73 16.78/27.02 15.21/24.49
E4f1 1.60/1.63 2.12/2.16 2.86/2.92 14.41/14.68 23.06/23.50 3.05/3.11 2.74/2.79
Eml4 1.08/1.61 4.20/6.27 1.20/1.79 2.43/3.63 2.77/4.15 2.32/3.47 2.45/3.66
Gabbr1 1.09/1.34 3.45/4.23 9.29/11.39 29.00/35.58 35.59/43.67 19.70/24.17 12.19/14.96
Glo1 3.48/4.60 1.46/1.93 3.77/4.98 3.69/4.87 2.29/3.03 4.37/5.77 6.12/8.08
Gm88 1.52/1.02 2.10/1.41 52.54/35.36 11.10/7.47 8.02/5.40 73.00/49.13 27.98/18.83
H2-M3 1.86/1.96 3.10/3.27 4.80/5.07 50.87/53.67 44.63/47.09 10.46/11.04 6.11/6.45
Hn1l 2.75/4.64 2.51/4.24 6.48/10.95 2.83/4.79 1.18/2.00 4.37/7.39 7.69/13.00
Hsf2bp 4.35/4.89 1.34/1.50 4.61/5.18 4.61/5.19 7.26/8.16 7.73/8.69 14.52/16.33
Khsrp 1.29/1.72 1.16/1.55 2.24/2.99 3.88/5.18 3.32/4.43 16.48/22.01 13.07/17.45
Mdc1 1.52/1.72 2.00/2.26 3.04/3.45 2.69/3.05 2.71/3.07 4.07/4.60 2.42/2.74
Mettl4 1.26/1.67 1.32/1.75 1.34/1.77 3.57/4.74 3.75/4.98 7.81/10.37 4.95/6.57
Mrps18a 2.16/3.03 1.25/1.75 2.71/3.80 1.90/2.67 1.52/2.14 3.50/4.91 3.08/4.32
Msh6 1.26/1.82 2.07/3.00 1.92/2.78 3.44/4.99 2.42/3.51 3.41/4.94 2.44/3.53
Ndufv2 1.76/2.27 1.52/1.96 1.42/1.82 1.64/2.11 1.59/2.05 2.38/3.06 2.02/2.60
Pdcd2 1.57/1.98 2.66/3.36 1.83/2.31 3.34/4.22 2.81/3.55 2.83/3.58 2.09/2.65
Pdpk1 1.51/2.36 1.27/1.99 1.17/1.83 3.12/4.88 2.17/3.41 1.46/2.29 1.74/2.72
Phf1 1.10/1.17 1.92/2.04 19.66/20.88 6.46/6.86 9.04/9.61 4.90/5.21 3.46/3.67
Pknox1 1.27/1.17 1.89/1.75 21.31/19.71 25.53/23.61 19.15/17.71 25.79/23.86 24.24/22.42
Polr1c 1.49/2.18 1.37/2.00 9.61/14.04 7.75/11.33 6.96/10.18 11.71/17.11 9.91/14.48
Prrt1 2.80/2.43 1.92/1.67 6.39/5.55 6.29/5.46 11.82/10.27 2.39/2.08 1.41/1.23
Psors1c2 6.73/5.81 1.31/1.13 12.72/10.98 13.83/11.94 12.50/10.79 8.46/7.30 8.08/6.98
Rab5a 1.08/1.42 1.34/1.75 4.47/5.86 7.74/10.15 8.45/11.08 3.48/4.56 3.64/4.78
Rdbp 1.22/1.55 1.48/1.88 1.93/2.45 2.51/3.18 1.42/1.80 4.19/5.32 3.61/4.58
Ring1 1.28/1.35 1.05/1.11 59.34/62.76 20.66/21.85 3.77/3.99 92.26/97.58 73.81/78.07
Rnps1 1.49/1.83 1.67/2.05 20.20/24.85 60.50/74.42 53.28/65.54 44.57/54.83 47.99/59.03
Skiv2l 1.44/1.33 1.55/1.44 25.93/24.00 24.77/22.93 20.72/19.18 4.41/4.09 3.28/3.04
Slc22a1 1.79/2.00 1.58/1.76 7.12/7.94 1.22/1.36 1.48/1.65 11.28/12.57 11.06/12.33
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Table 4 The down-regulated fold of specific genes in TCs as compared with others in chromosome 17 (Continued)
Slc25a23 1.03/1.45 1.28/1.79 44.78/62.78 3.84/5.38 2.57/3.61 40.36/56.58 32.46/45.51
Solh 1.21/1.22 1.24/1.24 88.56/89.01 148.74/149.50 153.65/154.43 111.96/112.53 76.12/76.51
Srd5a2 1.05/1.37 1.09/1.43 2.87/3.76 6.38/8.38 2.32/3.05 5.92/7.78 4.08/5.36
Srrm2 1.13/1.54 1.79/2.42 24.93/33.79 39.53/53.59 62.88/85.24 31.91/43.25 19.68/26.67
Stk38 1.55/1.43 1.09/1.00 10.55/9.75 64.22/59.33 56.48/52.17 28.77/26.58 12.08/11.16
Supt3h 1.91/1.52 2.66/2.12 15.28/12.16 16.32/12.98 12.85/10.22 49.56/39.43 27.98/22.27
Sytl3 1.15/1.28 1.06/1.19 4.59/5.14 4.63/5.18 6.65/7.44 10.58/11.85 5.56/6.23
Taf8 1.47/1.50 1.87/1.90 2.86/2.90 3.23/3.28 2.51/2.55 4.39/4.45 2.28/2.31
Tap1 3.12/2.15 1.91/1.32 25.60/17.68 173.22/119.61 180.68/124.76 46.31/31.97 36.19/24.99
Tbc1d5 1.03/1.16 1.53/1.72 1.16/1.31 1.18/1.33 1.32/1.49 2.09/2.35 1.13/1.27
Tbp 1.01/1.45 2.31/3.33 1.11/1.60 2.79/4.02 1.77/2.56 1.87/2.70 1.09/1.58
Tcf19 1.65/2.21 1.26/1.68 2.05/2.74 3.70/4.95 2.53/3.38 2.89/3.86 2.89/3.87
Telo2 1.35/1.69 1.69/2.13 1.35/1.70 1.43/1.80 1.35/1.69 4.90/6.16 3.84/4.83
Thumpd2 1.66/1.62 1.38/1.35 1.52/1.48 4.88/4.77 4.47/4.37 5.39/5.27 2.68/2.62
Wdr27 1.30/1.15 1.28/1.13 8.01/7.09 2.61/2.31 3.82/3.38 15.14/13.40 1.80/1.60
Wdr43 1.08/1.44 3.01/4.00 1.89/2.52 3.40/4.52 3.56/4.73 4.38/5.83 6.09/8.10
Zfp101 3.45/4.24 1.27/1.56 3.57/4.39 14.70/18.07 15.77/19.38 6.56/8.06 2.51/3.09
Zfp160 1.94/2.10 1.67/1.81 2.14/2.32 14.45/15.68 10.13/10.99 2.96/3.22 2.67/2.90
Zfp161 1.70/1.76 1.71/1.77 5.14/5.32 10.17/10.51 10.33/10.67 14.79/15.28 4.90/5.07
Zfp318 1.11/1.54 2.00/2.77 1.53/2.11 3.15/4.36 2.63/3.65 4.30/5.95 2.39/3.31
Zfp472 1.85/2.12 1.17/1.34 4.32/4.94 45.25/51.74 33.07/37.81 2.46/2.82 1.59/1.82
Zfp54 1.24/1.86 1.08/1.61 1.75/2.63 5.39/8.08 7.68/11.52 1.90/2.85 1.47/2.20
Zfp563 2.16/2.00 1.39/1.29 5.71/5.28 9.05/8.37 4.10/3.79 12.25/11.33 6.19/5.72
Zfp677 1.32/2.15 1.02/1.66 2.43/3.96 12.31/20.09 14.11/23.02 2.32/3.79 1.10/1.80
Znrd1 1.29/1.64 1.17/1.49 1.82/2.31 2.95/3.74 2.57/3.26 1.88/2.39 1.61/2.04
(B) Genes down-regulated between two- and fivefold in TCs as compared with others
C030034I22Rik 5.83/6.02 3.09/3.18 3.61/3.72 26.28/27.11 28.59/29.49 10.78/11.11 5.35/5.52
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in chromosomes 17 and 18 (Figure 2). Twenty six genes
presented close associations with each other. TCs-specific
genes which were up- or down-regulated in TC5 and TC10
were selected as gene clusters. Figures 3 and 4 demonstrated
differential changes of TCs-specific genes in TCs and other
cells. Top 20% up- or down-regulated genes in TC5 or
TC10 were extracted and compared with other cells via the
normalize gene expression data in either chromosomes 17
(Figure 5) or 18 (Figure 6). The result showed that high or
low expressed genes in TCs had few similarities with Fbs,
MSCs, ATII, ABCs, PACs, T-BL, or T-LL, respectively.Table 5 Summary of genes expressed preferentially in
TCs, as compared with others in chromosome 18
Compaired pairs/fold up-regulated >1 >2 >5
TC5 vs. others 14 8 0
TC10 vs. others 12 3 0
TCs vs. others 7 3 0Discussion
Chromosome 17 represents between 2.5 and 3 percent of
human genome while chromosome 18 approximately 2.7%
[30,31]. It has been reported that chromosomes 17 and 18
contained many disease-associated genes [32-37]. The
present study initially demonstrated TCs-specific genes, of
which 16 and 10 up-regulated and 68 and 22 down-
regulated, in chromosomes 17 and 18, respectively. Of them,
data from the present study indicated Mapk14, Trem2,
MCFD2, or Dpysl3 as the representative of up-regulated
genes and E4F1 and PDCD2 as the representative of down-
regulated genes, though the further study is needed.Table 6 Summary of genes expressed preferentially in
TCs, as compared with others in chromosome 18
Compaired pairs/fold down-regulated >1 >2 >5
TC5 vs. others 28 3 0
TC10 vs. others 50 6 1
TCs vs. others 20 2 0
Table 7 The up-regulated fold of specific genes in TCs as compared with others in chromosome 18
Folds(TC5 vs others/TC10 vs others)
(A) Genes up-regulated between one- and twofold in TCs as compared with others
Gene symbol Fibroblast Stem ATII CD8_T_BL CD8_T_LL Basal_cell Duct_cell
9430020K01Rik 1.16/1.02 1.85/1.64 1.47/1.30 24.11/21.33 55.70/49.26 5.37/4.75 6.55/5.79
Bin1 4.38/3.55 1.57/1.28 10.40/8.44 13.96/11.33 11.95/9.70 20.18/16.37 20.95/16.99
Cdh2 167.95/180.20 1.55/1.67 86.02/92.30 144.75/155.30 24.65/26.45 6.56/7.04 13.85/14.86
Fech 1.44/1.39 1.93/1.87 1.53/1.48 2.63/2.54 3.01/2.91 2.52/2.43 2.80/2.71
Txnl4a 2.14/1.46 1.78/1.21 2.04/1.39 2.85/1.94 2.95/2.01 2.74/1.87 2.84/1.94
Usp14 2.14/1.40 1.97/1.29 2.61/1.72 2.01/1.32 2.37/1.55 3.88/2.55 3.33/2.19
Yipf5 1.17/1.04 2.22/1.96 1.78/1.57 1.98/1.75 3.09/2.73 2.12/1.87 2.77/2.44
(B) Genes down-regulated between two- and fivefold in TCs as compared with others
Dpysl3 226.34/161.65 4.86/3.47 35.54/25.38 220.54/157.51 38.85/27.75 2.99/2.13 17.08/12.20
Lims2 2.16/2.42 28.92/32.46 6.04/6.77 119.74/134.38 174.63/195.98 37.64/42.24 393.49/441.60
Tubb6 5.38/3.70 3.96/2.73 25.62/17.62 457.27/314.51 267.70/184.12 16.55/11.38 9.71/6.68
Table 8 The down-regulated fold of specific genes in TCs as compared with others in chromosome 18
Folds(TC5 vs others/TC10 vs others)
(A) Genes up-regulated between one- and twofold in TCs as compared with others
Gene symbol Fibroblast Stem ATII CD8_T_BL CD8_T_LL Basal_cell Duct_cell
1700034H14Rik 2.01/2.59 1.13/1.46 2.11/2.72 11.70/15.08 10.71/13.80 6.98/9.00 5.12/6.59
2210409D07Rik 1.00/1.54 1.01/1.55 4.12/6.31 3.73/5.72 6.93/10.63 16.66/25.54 8.70/13.34
5430411K18Rik 1.94/2.09 1.26/1.36 2.71/2.92 4.24/4.56 4.50/4.85 2.92/3.15 2.54/2.74
Arhgap12 1.08/1.58 3.11/4.55 1.29/1.89 2.58/3.78 3.17/4.64 10.67/15.62 6.19/9.06
Arhgap26 1.13/1.17 1.49/1.54 8.78/9.06 18.96/19.57 13.15/13.57 70.65/72.91 35.92/37.07
Arsi 1.07/1.18 1.14/1.26 25.60/28.26 21.69/23.95 56.02/61.85 43.99/48.58 17.26/19.06
Hspa9 2.83/3.57 2.15/2.70 1.08/1.36 1.38/1.74 1.43/1.80 1.82/2.30 2.93/3.69
Impa2 3.99/4.10 1.36/1.39 1.30/1.34 1.65/1.69 1.66/1.71 2.94/3.02 3.17/3.26
Iws1 2.27/2.98 1.52/2.00 3.88/5.11 12.77/16.79 13.43/17.66 10.93/14.36 7.67/10.08
Map3k2 1.48/1.47 2.36/2.34 3.77/3.74 9.79/9.72 11.64/11.55 9.24/9.17 6.01/5.96
Mapk4 1.08/1.16 1.06/1.13 4.58/4.89 4.69/5.01 6.72/7.17 3.73/3.98 8.17/8.71
Matr3 2.04/3.30 1.17/1.89 8.32/13.47 19.84/32.15 23.19/37.58 7.76/12.57 9.33/15.11
Nfatc1 2.44/1.73 1.56/1.11 16.01/11.35 35.31/25.03 34.71/24.61 4.90/3.47 4.92/3.49
Pcdhb10 1.92/2.19 1.55/1.77 5.62/6.41 1.55/1.77 15.45/17.62 1.47/1.67 1.95/2.23
Pcdhb15 2.23/1.77 3.33/2.65 5.09/4.05 3.80/3.02 6.70/5.34 1.60/1.28 4.69/3.74
Pcdhb8 1.96/2.06 1.27/1.33 2.23/2.34 12.19/12.82 5.11/5.38 6.13/6.45 6.10/6.42
Seh1l 1.63/2.35 1.53/2.21 1.74/2.51 1.19/1.71 1.50/2.16 5.80/8.39 5.60/8.10
Snx24 2.08/1.96 1.10/1.04 131.64/124.43 1.36/1.29 1.71/1.62 84.17/79.56 26.83/25.36
Stard6 2.97/1.83 1.71/1.05 10.62/6.54 11.65/7.18 14.98/9.23 7.01/4.32 18.24/11.24
Tmed7 1.92/1.86 1.34/1.30 31.81/30.96 20.57/20.03 22.11/21.53 31.42/30.59 25.99/25.30
(B) Genes down-regulated between two- and fivefold in TCs as compared with others
Scgb3a2 2.14/3.14 2.16/3.17 4083.95/5996.46 2.25/3.30 6.29/9.24 6608.77/9703.65 3851.22/5654.77
Zfp397 2.34/3.46 2.52/3.71 2.24/3.31 2.78/4.11 2.89/4.26 8.71/12.84 3.70/5.46
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Table 9 The number of genes specifically up- or down-regulated in pulmonary telocytes, as compared with other cells
respectively in chromosome 17
Compaired pairs Up > 1 Up > 2 Up > 5 Down > 1 Down > 2 Down > 5 Down > 10
TC5 vs. stem 332 106 34 250 75 10 3
TC10 vs. stem 226 90 25 356 132 25 6
TCs vs. stem 220 68 19 244 68 8 3
TC5 vs. fibroblast 330 136 50 252 87 14 3
TC10 vs. fibroblast 245 95 36 337 124 22 4
TCs vs. fibroblast 229 84 31 236 79 9 2
TC5 vs. ATII 184 97 28 398 283 160 92
TC10 vs. ATII 139 71 19 443 333 193 114
TCs vs. ATII 134 61 15 393 227 151 85
TC5 vs. CD8BL 232 139 60 350 269 160 105
TC10 vs. CD8BL 194 113 40 388 300 175 115
TCs vs. CD8BL 185 100 37 341 261 149 97
TC5 vs. CD8LL 223 135 55 359 262 158 104
TC10 vs. CD8LL 177 105 43 405 301 170 122
TCs vs. CD8LL 170 99 39 352 254 150 95
TC5 vs. basal cell 153 77 28 429 332 201 120
TC10 vs. basal cell 120 59 23 462 377 238 150
TCs vs. basal cell 112 55 16 421 327 194 111
TC5 vs. duct cell 192 100 36 390 288 169 98
TC10 vs. duct cell 146 75 25 436 332 205 119
TCs vs. duct cell 142 67 20 386 282 165 88
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ent cellular functions, promote the production of pro-
inflammatory cytokines, and be involved in the response
to stress and metabolic pathways. p38 plays important
roles in the maintenance of homoeostasis and related
pathologies [38-40]. Trem2 is the member of Trem fam-
ily which is highly conserved in evolution in different
specials [41,42]. Trem2 negatively regulates cytokine
synthesis and plays an inhibitory regulator in inflamma-
tory response [43,44]. Telocytes were found to connect
with immune cells and regulate the immune response
[19]. Over-expressed Mapk14 gene in TCs may promote
the production and secretion of cytokines or other sig-
nal materials to induce inflammation, while up-regulated
Trem2 gene tends to inhibit inflammatory cytokine
synthesis to counteract the activation of p38. It seems
that TCs play a complicated and dual role in immune
surveillance and immune regulation. During the phys-
ical process, TCs can be activated to maintain homeo-
stasis to induce proliferation, differentiation and tissue
regeneration. On the other hand, TCs initiate the tis-
sue inflammation to induce pathogenesis under some
challenges.
MCFD2 encodes proteins involved in the transport of
FV and FVIII from the endoplasmic reticulum to theGolgi apparatus [45]. It is suggested that TCs play an
important role as an autocrine/paracrine factor in main-
taining stem cell potential and self-renewal [46,47]. TCs
were recently discovered to join the stem cells in the re-
generation and repair from myocardial infarction [48]. We
speculate that MCFD2 up-regulated in TCs may promote
positive interaction and intercommunication between TCs
and stem cells, and contribute to tissue injury and repair
by maintaining tissue homoeostasis. CRMP4 protein
encoded by Dpysl3 is strongly expressed in the developing
nervous system, and play a critical role in neuronal out-
growth and polarity, axon guidance and axonal protection,
and regeneration [49,50]. The features of neural axon have
great similarity with Tps of TCs on morphology and bio-
logical function. It is possible that up-regulated Dpysl3 is
indispensable for TCs self-proliferation and cell-cell net-
work forming.
E4F1 controls mammalian embryonic and somatic cell
proliferation and survival, and is a key posttranslational
regulator of p53, which modulates its effector functions
involved in cell growth arrest or apoptosis [51,52]. The
low expression of E4F1 in TCs has a positive effect on cell
proliferation and differentiation and maintains the viability
and activity of TCs in tissues. Programmed cell death 2
(PDCD2) is a highly conversed protein and expressed in
Table 10 The number of genes specifically up- or down-regulated in pulmonary telocytes, as compared with other cells
respectively in chromosome 18
Compaired pairs Up > 1 Up > 2 Up > 5 Down > 1 Down > 2 Down > 5 Down > 10
TC5 vs. stem 190 83 18 77 21 0 0
TC10 vs. stem 152 49 15 115 31 4 1
TCs vs. stem 143 42 9 68 17 0 0
TC5 vs. fibroblast 173 81 17 94 31 1 1
TC10 vs. fibroblast 140 46 11 127 45 5 1
TCs vs. fibroblast 130 44 10 84 24 0 0
TC5 vs. ATII 73 35 14 194 148 77 43
TC10 vs. ATII 58 25 12 209 165 99 56
TCs vs. ATII 52 22 11 188 146 73 41
TC5 vs. CD8BL 92 50 27 175 133 84 49
TC10 vs. CD8BL 69 42 20 198 153 94 59
TCs vs. CD8BL 66 36 18 172 131 80 47
TC5 vs. CD8LL 85 59 23 182 142 94 46
TC10 vs. CD8LL 74 39 18 193 160 104 63
TCs vs. CD8LL 69 37 17 177 138 90 45
TC5 vs. basal cell 54 31 10 213 178 116 66
TC10 vs. basal cell 44 23 9 223 194 140 84
TCs vs. basal cell 41 19 8 210 175 112 63
TC5 vs. duct cell 58 37 11 209 167 106 54
TC10 vs. duct cell 49 27 11 218 186 126 70
TCs vs. duct cell 48 22 9 208 164 102 52
Wang et al. Biology Direct  (2015) 10:9 Page 8 of 14embryonic and adult tissues widely. The transfection of a
construct expressing PDCD2 could induce apoptosis in
human cell lines [53]. Equally, TCs down-regulate the
PDCD2 to balance apoptosis and proliferation to maintain
the homeostasis.
Conclusion
The study globally analyzed the variation of genes in
chromosome 17 and 18 among pulmonary TCs, MSCs,
Fbs, ATII, ABCs, PACs, T-BL, and T-LL for the first time.
Approximately 15% and 12% genes in chromosomes 17
and 18 were identified as TCs-specific genes. The specific
up-regulated genes, i.e. Mapk14, Trem2, MCFD2 and
Dpysl3, and specific down-regulated genes, i.e. E4F1 and
PDCD2, in chromosome 17 and 18 made us have a deeper
insight into biological features and functions of TCs. It
has been found that TCs present morphological contact
with immune cells to form a cellular interaction network
to participate in immune regulation [19]. Our study re-
vealing variation of immune-associated genes in chromo-
some 17 and 18 gave an additional support to the essential
role of TCs in immune surveillance and immune homeo-
stasis which may protect from immune disorder in acute
and chronic pulmonary diseases. TCs also played a vitalrole in tissue proliferation, differentiation and regener-
ation to maintain the tissue homeostasis.
Reviewers’ comments
Reviewer 1: Dragos Cretoiu
This topic is original and the study provides new cues
within the field of the telocytes (TCs), a distinct type of
stromal cells. There are some minor issues which, if ad-
dressed, could improve the manuscript.
1) Introduction – There are more papers already pub-
lished regarding the presence of telocytes in different organs,
which might be worth mentioning. Some characteristics
of the immunophenotype and ultrastructure should also
be described.
Authors’ response: We have now described the pres-
ence of TCs in different organs and the characteristics of
the immunophenotype and ultrastructure in introduc-
tion paragraph.
The aim of the study is not clearly stated and therefore a
strong justification for the purpose of this study must be
included. Also, some discussion about the chromosome 2
and 3 gene expression profile in TCs should be mentioned.
Authors’ response: We revised and highlighted the
aim of our study to investigate features and patterns of
Figure 1 Hierarchical clustering of 582 genes in chromosomes 17 (A) and 267 genes 18 (B) among murine pulmonary telocytes (TCs),
mesenchymal stem cells (MSCs), fibroblasts (Fbs), alveolar type II cells (ATII), airwaybasal cells (ABCs), proximal airway cells (PACs),
CD8+ T cells from bronchial lymph nodes (T-BL) and CD8+ T cells from lungs (T-LL).
Wang et al. Biology Direct  (2015) 10:9 Page 9 of 14TCs-specific gene profiles and explore potential function
of TCs by focusing in chromosomes 17 and 18. It was
not only the first time but also a new method to mine
the TCs-specific gene profiles in chromosome 17 and 18.
We now also have made a discussion about the study for
the chromosome 2 and 3 gene expression profiles in
TCs, which had not been published before we submitted
this article.
2) Results – It would be useful for the readers to de-
scribe name of gene (or the encoded protein) at least for
the most significant ones.
Authors’ response: We completely agree with this sug-
gestion and have listed these significant genes in Tables 1,
2, 3, 4, 5, 6, 7 and 8.
3) Conclusion – I would suggest that this paragraph
should be re-written pointing out the specific novelty of this
study and the major findings leading to some functional hy-
potheses. Anyway, phrases like “Data from the present
study demonstrated TC-specific genes in chromosomes
17 and 18, although the mechanism of TCs-specific
genes in biological process of TCs needs to be further-
more explored” must be removed since is hampering theclarity and the significance of the study. TCs diversity ac-
cording to organ location is quite intriguing, even consid-
ering the proposed roles of this cell subset in immune
surveillance/tissue homeostasis. The authors should com-
ment more on this.
Authors’ response: We thank the reviewer’s advice
and have re-written the conclusion paragraph to high-
light the specific novelty of our study and TCs-specific
genes identification with its potential function in chro-
mosomes 17 and 18. Also, negative phrases like “Data
from the present study demonstrated TC-specific genes
in chromosomes 17 and 18, although the mechanism of
TCs-specific genes in biological process of TCs needs to
be furthermore explored” have been removed.
Besides, TCs was isolated from murine lung tissue in
this study. We have described the proposed roles of TCs
in immune surveillance/tissue homeostasis which may
protect from immune disorder in acute and chronic
pulmonary diseases. We think it’s really meaning to
differentiate the proposed roles of TCs subsets from
different organ location in further study, as reviewer
suggested.
Figure 2 The physical and functional interaction of specific genes by String Network analysis in chromosome 17 and 18.
Wang et al. Biology Direct  (2015) 10:9 Page 10 of 144) An English language revision is mandatory. Many
sentences should be rephrased. For example “The novel
feature of telocytes under TEM has extremely long TPs
with podomers and podoms, to contact with neighboring
or distant effectors like axinal of neuron”.
Quality of written English: Needs some language cor-
rections before being published.
Authors’ response: We have revised the article by an
English native specialist. I hope you are satisfied with the
revised version of the manuscript and hope it suitable for
the publication.
Reviewer 2: Qing Kay Li, Department of Pathology, Johns
Hopkins Medical Institutions
Although telocytes (TCs) have been found in a variety of
organs, TCs-specific biomarkers still need to be evalu-
ated. This manuscript studied the gene expression profiles
of murine pulmonary TCs and compared their profiles
with a variety of cell types, including mesenchymal stem
cells, fibroblasts, alveolar type II cells, airway basal cells,proximal airway cells, CD8+ T cells from bronchial lymph
nodes, and CD8+ T cells from the lung. In the study,
genes of chromosome 17 and 18 were extracted and
analyzed using bioinformatics tools, in order to identify
TCs-specific genes and their functional networks. They
found that 16 and 10 of TCs-specific genes were up-
regulated, and 68 and 22 were down-regulated in the
chromosome 17 and 18, respectively. Particularly,
Mapk14, Trem2, MCFD2 and Dpysl3 were up-regulated,
whereas the E4F1 and PDCD2 were down-regulated in
TCs. Their data demonstrated that the differential expres-
sion of subset of genes in chromosomes 17 and 18 were
unique features of pulmonary TCs, and they might be
used as biomarkers to distinguish TCs from the other type
of cells. Their findings were also suggestive of that TCs
might play critical roles in immune surveillance and other
intracellular functions.
Quality of written English: Acceptable.
Authors’ response: We appreciated Dr. Qing Kay Li’s
encouraging comment on this article.
Figure 3 TCs-specific genes in chromosome 17 were selected as a specific group. Each node stands for each given gene. The upper right
rectangular group represents up-regulated TCs-specific genes while the bottom left one represents down-regulated TCs-specific genes. Red nodes
show genes up-regulated while green nodes show genes down-regulated.
Figure 4 TCs-specific genes in chromosome 18 were selected as a specific group. Each node stands for each given gene. The upper right
rectangular group represents up-regulated TCs-specific genes while the bottom left one represents down-regulated TCs-specific genes. Red nodes
show genes up-regulated while green nodes show genes down-regulated.
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Figure 5 Top 20% up-regulated genes in TC10 was extracted and compared with the other cells via the normalize gene expression
data in chromosome 17. Each node stands for each given gene. The bottom right rectangular group represents top 20% up-regulated TC10
genes.Red nodes show genes up-regulated while green nodes show genes down-regulated.
Figure 6 Top 20% up-regulated genes in TC10 was extracted and compared with the other cells via the normalize gene expression
data in chromosome 18. Each node stands for each given gene. The bottom right rectangular group represents top 20% up-regulated TC10
genes.Red nodes show genes up-regulated, while green nodes show genes down-regulated.
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T-BL: CD8+ T cells from bronchial lymph nodes; TCs: Telocytes; TC5: TCs
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